These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 2155222

  • 1. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
    Tokumitsu H, Chijiwa T, Hagiwara M, Mizutani A, Terasawa M, Hidaka H.
    J Biol Chem; 1990 Mar 15; 265(8):4315-20. PubMed ID: 2155222
    [Abstract] [Full Text] [Related]

  • 2. Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma.
    Williams CL, Phelps SH, Porter RA.
    Biochem Pharmacol; 1996 Mar 08; 51(5):707-15. PubMed ID: 8615909
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A selective Ca2+/calmodulin-dependent protein kinase II inhibitor, KN-62, inhibits the enhanced phosphorylation and the activation of tyrosine hydroxylase by 56 mM K+ in rat pheochromocytoma PC12h cells.
    Ishii A, Kiuchi K, Kobayashi R, Sumi M, Hidaka H, Nagatsu T.
    Biochem Biophys Res Commun; 1991 May 15; 176(3):1051-6. PubMed ID: 1674865
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of insulin secretion by KN-62, a specific inhibitor of the multifunctional Ca2+/calmodulin-dependent protein kinase II.
    Wenham RM, Landt M, Walters SM, Hidaka H, Easom RA.
    Biochem Biophys Res Commun; 1992 Nov 30; 189(1):128-33. PubMed ID: 1333187
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Presence and possible involvement of Ca/calmodulin-dependent protein kinases in insulin release from the rat pancreatic beta cell.
    Niki I, Okazaki K, Saitoh M, Niki A, Niki H, Tamagawa T, Iguchi A, Hidaka H.
    Biochem Biophys Res Commun; 1993 Feb 26; 191(1):255-61. PubMed ID: 8383489
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phosphorylation of smooth muscle myosin light chain kinase by Ca2+/calmodulin-dependent protein kinase II: comparative study of the phosphorylation sites.
    Hashimoto Y, Soderling TR.
    Arch Biochem Biophys; 1990 Apr 26; 278(1):41-5. PubMed ID: 2157362
    [Abstract] [Full Text] [Related]

  • 17. The effect of KN-62, Ca2+/calmodulin dependent protein kinase II inhibitor on cell cycle.
    Minami H, Inoue S, Hidaka H.
    Biochem Biophys Res Commun; 1994 Feb 28; 199(1):241-8. PubMed ID: 8123019
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of regulated catecholamine secretion from PC12 cells by the Ca2+/calmodulin kinase II inhibitor KN-62.
    Schweitzer ES, Sanderson MJ, Wasterlain CG.
    J Cell Sci; 1995 Jul 28; 108 ( Pt 7)():2619-28. PubMed ID: 7593303
    [Abstract] [Full Text] [Related]

  • 20. Dependence of insulin secretion from permeabilized pancreatic beta-cells on the activation of Ca(2+)/calmodulin-dependent protein kinase II. A re-evaluation of inhibitor studies.
    Bhatt HS, Conner BP, Prasanna G, Yorio T, Easom RA.
    Biochem Pharmacol; 2000 Dec 01; 60(11):1655-63. PubMed ID: 11077048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.